Last updated on July 2014

Memory Loss?


Brief description of study

Memory Loss?

Detailed Study Description

California Neuroscience Research is conducting a research study on the effectiveness and safety of an investigational medication or placebo in patients with mild Alzheimer’s disease. The study has up to 31 office visits over up to 40 months. Participants will receive an investigational medication or placebo monthly by subcutaneous injection.

Alzheimer’s disease is characterized by progressive memory impairment, as well as problems in:

  • Language
  • Recognition
  • Carrying out tasks
  • Planning or organizing

Clinical Study Identifier: TX138902

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.